Articles

Breast-feeding may protect the nursing mother from metabolic syndrome, according to the results of a prospective, observational cohort study.

Blood samples were analyzed for differences (mutations) in DNA and RNA that affect the level of gene expression. The result of these mutations would cause the individual to be less able to metabolize carbohydrates.

New research shows that the risk of heart attack, stroke, sudden cardiac death and diabetes in men who underwent androgen deprivation therapy was 20 to 30 percent higher.

Among people with diabetes, those who develop foot ulcers seem to die earlier than those without the complication, a new study finds.

Eli Lilly and Company, and Amylin announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with Type 2 diabetes.  

Elevated 1-hour plasma glucose (1hPG) levels in persons without overt diabetes (DM) may be a marker for cardiovascular risk, according to the results of a study.  

The drug rituximab already used to treat autoimmune disorders may also slow the destruction of insulin-producing cells in patients with insulin-dependent (Type 1) diabetes.

Novo Nordiskstarted the first human tests on an experimental insulin pill, NN1952, joining companies seeking to develop an alternative to daily injections for diabetes patients who need the hormone to control their disease.  

Proton pump inhibitor therapy is associated with improved hemoglobin A1c levels in non-insulin-dependent Type 2 diabetes patients, based on results from two retrospective studies.

Injecting the corticosteroid triamcinolone into the eye may slow the progression of diabetic retinopathy, a complication of diabetes that can cause vision loss and blindness, according to a report.